Abstract
The aim of this study was to explore whether there is a relationship between cataract and Alzheimer’s disease in older people in Taiwan. We conducted a retrospective cohort study by using the database of the Taiwan National Health Insurance Program from 1999 to 2004. There were 19,954 subjects aged 65–84 with newly diagnosed cataract as the cataract group and 19,954 randomly selected subjects without cataract as the non-cataract group. Both groups were matched with sex, age and index year of diagnosing cataract. The risk of Alzheimer’s disease associated with cataract was assessed. The overall incidence of Alzheimer’s disease was 1.21 per 1,000 person-years in the cataract group and 0.73 per 1,000 person-years in the non-cataract group (crude hazard ratio 1.62, 95 % CI 1.28, 2.04). After adjustment for potential confounders, the adjusted HR of Alzheimer’s disease was 1.43 (95 % CI 1.13, 1.82) for the cataract group, compared to the non-cataract group. Male (HR 1.36, 95 % CI 1.09, 1.70), age (every 1 year, HR 1.08, 95 % CI 1.06, 1.10) and head injury (HR 1.79, 95 % CI 1.08, 2.96) were other factors significantly associated with Alzheimer’s disease. Older people with cataract are at 1.43-fold increased risk of developing Alzheimer’s disease. More research is necessary to determine whether cataract is one of non-memory features of Alzheimer’s disease.
Similar content being viewed by others
References
Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement. 2007;3(3):186–91. doi:10.1016/j.jalz.2007.04.381.
Di Carlo A, Baldereschi M, Amaducci L, et al. Incidence of dementia, Alzheimer’s disease, and vascular dementia in Italy. The ILSA study. J Am Geriatr Soc. 2002;50(1):41–8.
Imfeld P. Brauchli Pernus YB, Jick SS, Meier CR. Epidemiology, co-morbidities, and medication use of patients with Alzheimer’s disease or vascular dementia in the UK. J Alzheimers Dis. 2013;35(3):565–73. doi:10.3233/jad-121819.
Mathuranath PS, George A, Ranjith N, et al. Incidence of Alzheimer’s disease in India: a 10 years follow-up study. Neurol India. 2012;60(6):625–30. doi:10.4103/0028-3886.105198.
Chan KY, Wang W, Wu JJ, et al. Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990–2010: a systematic review and analysis. Lancet. 2013;381(9882):2016–23. doi:10.1016/s0140-6736(13)60221-4.
Koedam EL, Lauffer V, van der Vlies AE, van der Flier WM, Scheltens P, Pijnenburg YA. Early-versus late-onset Alzheimer’s disease: more than age alone. J Alzheimers Dis. 2010;19(4):1401–8. doi:10.3233/jad-2010-1337.
Mendez MF, Lee AS, Joshi A, Shapira JS. Nonamnestic presentations of early-onset Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 2012;27(6):413–20. doi:10.1177/1533317512454711.
Mendez MF. Early-onset Alzheimer’s disease: nonamnestic subtypes and type 2 AD. Arch Med Res. 2012;43(8):677–85. doi:10.1016/j.arcmed.2012.11.009.
Pal S, Sanyal D, Biswas A, Paul N, Das SK. Visual manifestations in Alzheimer’s disease: a clinic-based study from India. Am J Alzheimers Dis Other Demen. 2013;28(6):575–82. doi:10.1177/1533317513494448.
Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96(5):614–8. doi:10.1136/bjophthalmol-2011-300539.
Abraham AG, Condon NG, West Gower E. The new epidemiology of cataract. Ophthalmol Clin North Am. 2006;19(4):415–25. doi:10.1016/j.ohc.2006.07.008.
Prokofyeva E, Wegener A, Zrenner E. Cataract prevalence and prevention in Europe: a literature review. Acta Ophthalmol. 2013;91(5):395–405. doi:10.1111/j.1755-3768.2012.02444.x.
Lai SW, Liao KF, Liao CC, Muo CH, Liu CS, Sung FC. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore). 2010;89(5):295–9. doi:10.1097/MD.0b013e3181f15efc.
Lai SW, Chen PC, Liao KF, Muo CH, Lin CC, Sung FC. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study. Am J Gastroenterol. 2012;107(1):46–52. doi:10.1038/ajg.2011.384.
Lai SW, Lin CH, Liao KF, Su LT, Sung FC, Lin CC. Association between polypharmacy and dementia in older people: a population-based case–control study in Taiwan. Geriatr Gerontol Int. 2012;12(3):491–8. doi:10.1111/j.1447-0594.2011.00800.x.
Liao KF, Lai SW, Li CI, Chen WC. Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan. J Gastroenterol Hepatol. 2012;27(4):709–13. doi:10.1111/j.1440-1746.2011.06938.x.
Goldstein LE, Muffat JA, Cherny RA, et al. Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer’s disease. Lancet. 2003;361(9365):1258–65. doi:10.1016/s0140-6736(03)12981-9.
Moncaster JA, Pineda R, Moir RD, et al. Alzheimer’s disease amyloid-beta links lens and brain pathology in Down syndrome. PLoS ONE. 2010;5(5):e10659. doi:10.1371/journal.pone.0010659.
Jun G, Moncaster JA, Koutras C, et al. Delta-Catenin is genetically and biologically associated with cortical cataract and future Alzheimer-related structural and functional brain changes. PLoS ONE. 2012;7(9):e43728. doi:10.1371/journal.pone.0043728.
Casley CS, Land JM, Sharpe MA, Clark JB, Duchen MR, Canevari L. Beta-amyloid fragment 25–35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol Dis. 2002;10(3):258–67.
Abramov AY, Canevari L, Duchen MR. Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci. 2004;24(2):565–75. doi:10.1523/jneurosci.4042-03.2004.
Walls KC, Coskun P, Gallegos-Perez JL, et al. Swedish Alzheimer mutation induces mitochondrial dysfunction mediated by HSP60 mislocalization of amyloid precursor protein (APP) and beta-amyloid. J Biol Chem. 2012;287(36):30317–27. doi:10.1074/jbc.M112.365890.
Jarrett SG, Lewin AS, Boulton ME. The importance of mitochondria in age-related and inherited eye disorders. Ophthalmic Res. 2010;44(3):179–90. doi:10.1159/000316480.
Babizhayev MA. Mitochondria induce oxidative stress, generation of reactive oxygen species and redox state unbalance of the eye lens leading to human cataract formation: disruption of redox lens organization by phospholipid hydroperoxides as a common basis for cataract disease. Cell Biochem Funct. 2011;29(3):183–206. doi:10.1002/cbf.1737.
Mancuso M, Calsolaro V, Orsucci D, et al. Mitochondria, cognitive impairment, and Alzheimer’s disease. Int J Alzheimers Dis. 2009;. doi:10.4061/2009/951548.
Maruszak A, Zekanowski C. Mitochondrial dysfunction and Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(2):320–30. doi:10.1016/j.pnpbp.2010.07.004.
Brennan LA, Kantorow M. Mitochondrial function and redox control in the aging eye: role of MsrA and other repair systems in cataract and macular degenerations. Exp Eye Res. 2009;88(2):195–203. doi:10.1016/j.exer.2008.05.018.
Acknowledgments
This study was supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (Grant Number DOH102-TD-B-111-004) and China Medical University Hospital (Grant Number 1MS1). The funding agency did not influence the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Conflict of interest
The authors disclose no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lai, SW., Lin, CL. & Liao, KF. Cataract may be a non-memory feature of Alzheimer’s disease in older people. Eur J Epidemiol 29, 405–409 (2014). https://doi.org/10.1007/s10654-014-9903-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-014-9903-6